Используйте голову, чтобы спасти мозг. Профилактика деменции в любом возрасте

Arvanitakis Z, Shah RC, Bennett DA. Diagnosis and management of dementia: review. J Am Med Assoc. 2019;322(16):1589–1599. doi: 10.1001/jama.2019.4782

Barker WW, Luis CA, Kashuba A, et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord. 2002;16(4):203–212. doi: 10.1097/00002093-200210000-00001

Benjamin S, MacGillivray L, Schildkrout B, Cohen-Oram A, Lauterbach MD, Levin LL. Six landmark case reports essential for neuropsychiatric literacy. J Neuropsychiatry Clin Neurosci. 2018;30(4):279–290. doi: 10.1176/appi.neuro psych.18020027. Epub 2018 Aug 24.

Blazer DG, Yaffe K, Liverman C, eds. Cognitive aging: progress in understanding and opportunities for action. National Academies Press; 2015. doi: 10.17226/21693

Boyle PA, Yu L, Wilson RS, Schneider JA, Bennett DA. Relation of neuropathology with cognitive decline among older persons without dementia. Front Aging Neurosci. 2013;9(5):50. doi: 10.3389/fnagi.2013.00050

Clionsky M, Clionsky E. Identifying cognitive impairment in the annual wellness visit: who can you trust? J Fam Pract, 2011;60(11):653–659.

Dang, C, Maruff, P. SuperAging: current findings yield future challenge: A response to Rogalski and Goldberg. Alzheimers Dement (Amst). 2019;11:562–563. doi: 10.1016/j.dadm.2019.05.004

DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer’s disease. Mol Neurodegener. 2019;14(32). doi: 10.1186/s13024-019-0333-5

Drachman DA. The amyloid hypothesis, time to move on: amyloid is the downstream result, not cause, of Alzheimer’s disease. Alzheimers Dement. 2014 May;10(3):372–380. doi: 10.1016/j.jalz.2013.11.003

Dubois B, Hampel H, Feldman HH, et al. Proceedings of the Meeting of the International Working Group (IWG) and the American Alzheimer’s Association on “The preclinical state of AD”; July 23, 2015; Washington DC, USA. Preclinical

Alzheimer’s disease: Definition, natural history, and diagnostic criteria. Alzheimers Dement. 2016;12(3):292–323. doi: 10.1016/j.jalz.2016.02.002

Elahi F, Miller B. A clinicopathological approach to the diagnosis of dementia. Nat Rev Neurol. 2017 Aug;13(8):457–476. doi: 10.1038/nrneurol.2017.96

Fox N, Petersen R. The G8 Dementia Research Summit – a starter for eight? Lancet. 2013;382(9909):1968–1969. doi: 10.1016/S0140-6736(13)62426–5

Goodman RA, Lochner KA, Thambisetty M, Wingo TS, Posner SF, Ling SM. Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011–2013. Alzheimers Dement. 2017 Jan;13(1):28–37. doi: 10.1016/ j.jalz.2016.04.002. Epub 2016 May 10.

Graff-Radford J. Vascular cognitive impairment. Continuum. 2019 Feb;25(1):147–164. doi: 10.1212/CON.0000000000000684

Hale JM, Schneider DC, Mehta NK, Myrskyla M. Cognitive impairment in the U.S.: lifetime risk, age at onset, and years impaired. SSM Popul Health. 2020;11:100577. doi: 10.1016/j.ssmph.2020.100577. Erratum in: SSM Popul Health. 2020 Dec 10;12:100715.

Imtiaz B, Tolppanen AM, Kivipelto M, Soininen H. Future directions in Alzheimer’s disease from risk factors to prevention. Biochem Pharmacol. 2014;88(4):661–670. doi: 10.1016/j.bcp.2014.01.003. Epub 2014 Jan 10.

Kapasi A, DeCarli C, Schneider JA. Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol. 2017;134(2):171–186. doi: 10.1007/s00401-017-1717-7. Epub 2017 May 9.

Katzman R. The prevalence and malignancy of Alzheimer disease: a major killer. Alzheimers Dement. 2008;4(6):378–380. doi: 10.1016/j.jalz.2008.10.003. Epub 2008 Oct 22.

Knopman DS, Petersen RC, Jack CR. A brief history of “Alzheimer disease”: multiple meanings separated by a common name. Neurology, 2019; 92(22):1053–1059. doi: 10.1212/WNL.0000000000007583

Marin-Oto M., Vicente EE, Marin JM. Long term management of obstructive sleep apnea and its comorbidities. Multidiscip Respir Med, 2019;14(1). doi: 10.4081/mrm.2019.24

Meusel L-AC, Greenwood CE, Maione A, Tchistiakova E, MacInstosh BJ, Anderson NC. Cardiovascular risk and encoding-related hippocampal connectivity in older adults. BMC Neurosci, 2019;20(37). doi: 10.1186/s12868-019-0518-4

Neumann MA, Cohn R. Incidence of Alzheimer’s disease in large mental hospital; relation to senile psychosis and psychosis with cerebral arteriosclerosis. Arch Neurol Psychiatry. 1953; 69 (5): 615–636. doi: 10.1001/archneurpsyc.1953.02320290067008

Nowakowski RS. Stable neuron numbers from cradle to grave. Proc Natl Acad Sci 220 For Further Reading USA. 2006;103(33):12219–12220. doi: 10.1073/pnas.0605605103. Epub 2006 Aug 7.

Penke B, Szucs M, Bogar F. Oligomerization and conformational change turn monomeric ?-amyloid and tau proteins toxic: their role in Alzheimer’s pathogenesis. Molecules. 2020; 25. doi: 10.3390/molecules25071659

Rodriguez RD, Grinberg L. Argyrophilic grain disease: an underestimated tauopathy. Dement Neuropsychol. 2015;9:2–8. doi: 10.1590/S1980-57642015 DN91000002

Strassnig M, Ganguli M. About a peculiar disease of the cerebral cortex: Alzheimer’s original case revisited. Psychiatry. 2005;2:30–33.

Volk B. How to keep your brain from shrinking. Life Extension Magazine. https://www.lifeextension.com/magazine/2015/2/combat-age-related-brain-atrophy?utm_source=cj.com&utm_medium=affiliate&utm_campaign=5250933&cjevent=37c6e18e850611eb82fa035f0a240613

Wang H, Li T, Barbarino P, et al. Dementia care during COVID-19. Lancet. 2020; 395(10231):1190–1191. doi: 10.1016/S0140-6736(20)30755-8. Epub 2020 Mar 30.

Yu J-T, Xu W, Tan C–C, et al. Evidence-based prevention of Alzheimer’s disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials. J Neurol Neurosurg. 2020. doi: 10.1136/jnnp-2019-321913

Chapter 2. Normal Cognitive Aging

Andersen SL. Centenarians as models of resistance and resilience to Alzheimer’s disease and related dementias. Adv Geriatr Med Res. 2020;2(3):e200018. doi: 10.20900/agmr20200018. Epub 2020 Jul 3.

Boldrini M, Fulmore CA, Tartt AN, et al. Human hippocampal neurogenesis persists throughout aging. Cell Stem Cell. 2018;22(4):589–599.e5. doi: 10.1016/ j.stem.2018.03.015

Boyle PA, Wilson RS, Yu L, et al. Much of late life cognitive decline is not due to common neurodegenerative pathologies. Ann Neurol. 2013;74(3):478–489. doi: 10.1002/ana.23964. Epub 2013 Jul 10.